Your browser doesn't support javascript.
loading
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer.
Chen, Yi-Xin; Tan, Li-Ming; Gong, Jian-Ping; Huang, Ma-Sha; Yin, Ji-Ye; Zhang, Wei; Zhou, Hong-Hao; Liu, Zhao-Qian.
Afiliação
  • Chen YX; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Tan LM; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
  • Gong JP; Department of Pharmacy, The Second People's Hospital of Huaihua City, Huaihua, 418000, China.
  • Huang MS; Department of Pharmacy, The Second People's Hospital of Huaihua City, Huaihua, 418000, China.
  • Yin JY; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhang W; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
  • Zhou HH; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Liu ZQ; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
Acta Pharmacol Sin ; 42(12): 1970-1980, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33589795
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores / Inibidores de Poli(ADP-Ribose) Polimerases / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores / Inibidores de Poli(ADP-Ribose) Polimerases / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article